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Background: During fetal brain development in mammals, newborn neurons undergo cell migration to reach their
appropriate positions and form functional circuits. We previously reported that the atypical RhoA GTPase Rnd2
promotes the radial migration of mouse cerebral cortical neurons (Nature 455(7209):114–8, 2008; Neuron
69(6):1069–84, 2011), but its downstream signalling pathway is not well understood.
Results: We have identified BTB-domain containing adaptor for Cul3-mediated RhoA degradation 2 (Bacurd2) as a
novel interacting partner to Rnd2, which promotes radial migration within the developing cerebral cortex. We find
that Bacurd2 binds Rnd2 at its C-terminus, and this interaction is critical to its cell migration function. We show
that forced expression or knockdown of Bacurd2 impairs neuronal migration within the embryonic cortex and alters
the morphology of immature neurons. Our in vivo cellular analysis reveals that Bacurd2 influences the multipolar-
to-bipolar transition of radially migrating neurons in a cell autonomous fashion. When we addressed the potential
signalling relationship between Bacurd2 and Rnd2 using a Bacurd2-Rnd2 chimeric construct, our results suggest
that Bacurd2 and Rnd2 could interact to promote radial migration within the embryonic cortex.
Conclusions: Our studies demonstrate that Bacurd2 is a novel player in neuronal development and influences
radial migration within the embryonic cerebral cortex.
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During mammalian brain development, newborn neu-
rons undergo a well-defined migratory journey in order
to arrive at their final location within the developing
nervous system and form functional connections with
other neural cells [1-3]. Following their birth within the
germinal zone of the ventricular neuroepithelium (known
as the ventricular zone (VZ)), they migrate through a tran-
sitional intermediate zone (IZ) before arriving at their
appropriate positions within the cortical plate (CP) and
undergo terminal differentiation. Failure in the proper po-
sitioning of neurons during brain development can result* Correspondence: julian.heng@perkins.uwa.edu.au
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unless otherwise stated.in the formation of abnormal neural circuits, leading to in-
tellectual impairment and epilepsy in humans [4,5].
While the molecular mechanisms which govern cell
migration during brain development are not fully under-
stood, recent work has revealed that neuronal migration
is intrinsically regulated by the activity of DNA binding
transcription factors on a RhoA-like GTPase gene known
as Rnd2 [6,7]. It was discovered that members of the basic
helix-loop-helix (bHLH) family of transcriptional activa-
tors (such as Neurog2, NeuroD1 and NeuroD2) stimulate
Rnd2 expression to promote the migration of newborn ex-
citatory neurons of the cerebral cortex [6,8]. Furthermore,
transcriptional repressors such as COUP-TFI and RP58
negatively regulate Rnd2 expression in the course of their
radial migration and control their multipolar-to-bipolar
conversion within the IZ as they enter the CP to complete
their migration [9-11]. Together, these multiple regulatoryntral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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in neurons to shape their development during cortical
neurogenesis.
Despite a deep understanding of the regulation of Rnd2
expression for the positioning of neurons within the nas-
cent cortex, the intracellular signalling pathways through
which Rnd2 controls cell migration remain less well
understood. Nevertheless, Rnd2 and its related family
member Rnd3 are both known to control radial migration
and neurite outgrowth through their actions on the actin
cytoskeleton [6,7,12]. However, while recent studies dem-
onstrate that both Rnd proteins commonly suppress RhoA
signalling and modulate the filamentous-actin (F-actin)
cytoskeleton within cortical neurons as they differentiate
within the embryonic cortex [7], the underlying signalling
mechanisms for Rnd2 and Rnd3 are known to be different.
Notably, Rnd3 mediates actin depolymerisation and
promotes cell migration within the embryonic cortex
through its downstream effector molecule p190Rho-
GAP, while Rnd2 does not signal through this pathway
[7]. In addition, Rnd proteins are known to interact with
different protein partners in order to elicit their effects
on fibroblast cell shape and motility (reviewed in [13,14]),
thus the challenge remains to better understand the com-
plexity of the downstream signalling pathways through
which Rnds function in neural cells as well.
In this study, we wanted to clarify the signalling path-
way through which Rnd2 mediates cell migration during
neuronal development in mice. We have identified a
member of the BTB-domain containing adaptor for Cul3-
mediated RhoA degradation (Bacurd2) as a novel binding
partner to Rnd2 within the mouse embryonic cerebral
cortex. We report that knockdown or forced expression of
Bacurd2 disrupts radial cell migration in vivo and that
Bacurd2 promotes the multipolar-to-bipolar transition of
neurons as they transit from the intermediate zone into
the cortical plate. In our exploration of the functions for
Bacurd2 and Rnd2, we find both to be crucial to the
migration of newborn neurons within the embryonic
cerebral cortex.
Results
Bacurd2 interacts with Rnd2 and mediates cell migration
within the embryonic cerebral cortex
To identify binding partners to Rnd2, we performed a
yeast two-hybrid screen of an embryonic mouse (E15.5)
cortex library [15] using an Rnd2 bait construct lacking
the C-terminal membrane-binding (CAAX) motif. A sur-
vey of 2 × 107 independent clones resulted in the isolation
of multiple interacting prey clones encoding polypeptides
corresponding to full-length Bacurd2, as well as a smaller
fragment comprising the C-terminal aa242-316 fragment.
Following prey plasmid recovery, complementation tests
confirm specificity of interaction between Bacurd2 preysand the Rnd2 bait, but not pLaminC or with p53
(Additional file 1: Figure S1). To confirm protein-protein
interaction between Bacurd2 and Rnd2, we performed
immunoprecipitation experiments with epitope-tagged
constructs and found that FLAG-tagged Rnd2 binds to
EGFP-Bacurd2 fusion protein, but not to EGFP alone
(Figure 1A). We also performed immunoprecipitation
experiments with mouse embryonic (E14.5) brain lysate
using a Bacurd2 antibody (Additional file 2: Figure S2A)
to confirm their interaction in vivo (Figure 1B). Bacurd2
and Rnd2 are detected throughout the course of brain
development (Additional file 2: Figure S2C). Immuno-
staining of embryonic E14.5 cerebral cortex tissue revealed
Bacurd2 signal in the VZ, sVZ and IZ, while parallel ex-
periments performed with pre-immune serum did not
elicit a signal (Additional file 2: Figure S2D-E).
Next, we performed a series of in utero electroporation
experiments on E14.5 mouse embryonic cortex to deter-
mine whether perturbations to Bacurd2 might disrupt
cortical development. To do this, we forced expressed
Bacurd2 by delivering a bicistronic expression construct
encoding Bacurd2 and GFP into embryonic cortical cells
and examined the distribution of GFP-labelled cells 3 days
later at E17.5. In a reciprocal approach, we suppressed
Bacurd2 expression in cells using targeting siRNAs to-
gether with an empty (GFP only) vector (Figure 2A). In
each condition, the amounts of siRNA (control or target-
ing) and expression vector (GFP only, or GFP + Bacurd2
bicistronic vector) were normalised to enable comparisons
across conditions. In Figure 2B, we show that while a sig-
nificant proportion of GFP-labelled cells had migrated
into the CP of control-treated brains, forced expression
of Bacurd2 or knockdown with siRNAs disrupted their
migration within the embryonic cortex, observed as an
accumulation of cells within the IZ and a concomitant
decrease in cells located within the CP (Figure 2C).
Within the CP, a significant proportion of Bacurd2-
overexpressing cells and Bacurd2 siRNA-treated cells
failed to reach the upper cortical plate, suggesting that
changes to Bacurd2 levels disrupt their ‘intracortical’
positioning (Figure 2D). To account for the possibility
that disruptions to Bacurd2 might influence cortical
neurogenesis, we performed quantification studies and
found no significant differences in the proportions of
GFP+/Tuj1+ cells or their distribution within the subcom-
partments of the embryonic E17.5 cortex (Additional
file 3: Figure S3).
To confirm the specificity of the siRNA-mediated mi-
gration defect, we performed rescue experiments whereby
cells were co-treated with an expression construct encod-
ing human BACURD2 which was refractory to RNAi
(Figure 3). Our results show that the defective migration
of siRNA-treated cells could be significantly restored to
levels resembling control condition when 0.4 μg/μl of
Figure 1 Bacurd2 interacts with Rnd2 in vitro and in vivo. (A) Immunoprecipitation assays with transiently transfected HEK293T cells show
that FLAG-Rnd2 interacts with EGFP-Bacurd2, but not EGFP. (B) Lysates of E14.5 mouse brain homogenates were immunoprecipitated with a Bacurd2
antibody and probed by immunoblotting for Rnd2 to confirm their interaction in vivo. As a control, mouse-anti-IgG did not immunoprecipitate Rnd2.
Input lanes confirm protein expression in both experiments. Further details of antibodies used to detect Bacurd2 and Rnd2 are provided in Additional
file 2: Figure S2.
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siRNA (Figure 3C). Interestingly, while co-treatment
with either concentrations of BACURD2 enhanced mi-
gration into the CP (Additional file 4: Figure S4), we
show in Figure 3C,D that the migration profile of siRNA-
treated cells was corrected to levels resembling control
when co-treated with 0.4 μg/μl of BACURD2 (Figure 3C),
while co-treatment with a higher concentration (1 μg/μl)
of BACURD2 construct disrupted intracortical positioning
(Figure 3D). Thus, Bacurd2 cell autonomously controls ra-
dial migration, with concentration-sensitive effects.
In the course of their radial migration, embryonic cor-
tical cells adopt different modes of migration from the
germinal VZ, through to the IZ and the CP [16,17].
Hence, we analysed the morphology of GFP-labelled
neurons to describe the cellular basis for the defective
migration of cells as a result of perturbations to Bacurd2.
Within the IZ, we found that forced expression of
Bacurd2 resulted in a significant increase in the propor-
tion of round-shaped cells which have very short pro-
cesses (or no detectable processes at all), together with a
corresponding decrease in multipolar-shaped neurons;
while the proportion of uni/bipolar-shaped neurons was
not significantly different (Figure 4). On the other hand,
knockdown of Bacurd2 resulted in a significant increase
in the proportion of multipolar-shaped neurons and a
concomitant decrease in uni/bipolar neurons, while the
proportion of round-shaped neurons was not significantly
different. Within the CP, we found that forced expression
as well as knockdown of Bacurd2 resulted in an increase
in the proportion of round-shaped cells, together with a
decrease in the proportions of uni/bipolar-shaped cells.
These documented changes in cell morphology upon
siRNA-mediated knockdown were corrected by co-
delivery of 0.4 μg/μl BACURD2 construct (Additional
file 5: Figure S5). Together, these results demonstrate
that disruptions to Bacurd2 alter the morphologies ofembryonic neurons, and this effect could underlie their
defective migration within the embryonic E17.5 cortex.
In the following experiments, we wanted to define the
interaction domains on Bacurd2 which govern its bind-
ing to Rnd2. We cloned truncation mutants of Bacurd2
based on the minimal interaction regions identified in
our yeast two-hybrid assay (Additional file 1: Figure S1)
and assessed their interaction in co-immunoprecipitation
assays using epitope-tagged proteins in heterologous cells
(Figure 5). Our results show that while a C-terminal trun-
cation mutant Bacurd2(Δ221-316) fails to immunoprecipi-
tate Rnd2, an N-terminal mutant Bacurd2(Δ1-109) still
interacts with Rnd2 (Figure 5B, lanes 3 to 4). Recently,
Bacurd2 was demonstrated to interact with the E3 ubiqui-
tin ligase Cul3 at its N-terminus and signal together to
promote fibroblast cell migration in vitro [18]. Given that
Bacurd2, Rnd2 and Cul3 proteins are all present during
mouse brain development (Additional file 2: Figure S2C),
we wanted to confirm their protein-protein interaction.
As shown, our co-immunoprecipitation experiments re-
veal that while Cul3 interacts with full-length Bacurd2, as
well as a C-terminal truncation mutant, the N-terminal
mutant Bacurd2(Δ1-109) fails to immunoprecipitate Cul3
(Figure 5C). In addition, we engineered missense muta-
tions I71A/L72A/I73A to Bacurd2 (named as Bacurd2(3A),
the location of these amino acids are indicated in
bold text on Figure 5A) which are reported to disrupt its
BTB domain [18], and we found that this variant did not
interact with Cul3 (Figure 5D). Therefore, these studies
demonstrate that Bacurd2 interacts with Rnd2 as well as
Cul3 via the C- and N-termini, respectively (summarised
in Figure 5E).
Next, we investigated how the Bacurd2 polypeptide
influences neuronal migration by performing in utero
electroporation assays. Specifically, we asked if forced
expression of each of the mutated variants of
Bacurd2 (that is Bacurd2(Δ1-109), Bacurd2(3A) and
Figure 2 Bacurd2 influences cell migration within the embryonic mouse cerebral cortex. (A) Western blotting with HEK293T cell lysates
confirms that FLAG-Bacurd2 expression is suppressed by targeting siRNAs, but not by control (non-targeting) siRNAs. Actin was used as loading
control. (B) In utero electroporation was performed on embryonic mouse E14.5 embryos and analysed 3 days later at E17.5. Cortical cells were
electroporated with control vector (GFP only), a bicistronic GFP expression construct which also encodes Bacurd2, or Bacurd2 siRNA co-electroporated
with GFP vector. (C) Quantification reveals that forced expression of Bacurd2, or treatment with Bacurd2 siRNAs, alters the distribution of cells within
the embryonic cortex (N > 4,500 cells from four to six brains per condition; F4,72 = 14.97; P < 0.0001; two-way ANOVA followed by Bonferroni’s post
hoc test; ****P < 0.0001. (D) Quantification of GFP+ cells within the CP (divided into the lower, medial and upper CP) reveals that forced expression of
Bacurd2 or knockdown of Bacurd2 disrupts the intracortical distribution of GFP+ cells compared with control (N > 1,500 cells from four to six brains
per condition; F4,72 = 27.89; P < 0.0001; two-way ANOVA followed by Bonferroni’s post hoc test). uCP, mCP and lCP indicate upper, medial and
lower cortical plates, respectively. Scale bar represents 100 μm.
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embryonic cortical cells within the E17.5 cortex in a similar
manner to wildtype Bacurd2. As shown in Figure 6, we
found that while forced expression of full-length Bacurd2
disrupted the migration of embryonic cortical cells into
the CP, forced expression of the N-terminal truncation
mutants Bacurd2(Δ1-109) or Bacurd2(3A) (both of which
fail to interact with Cul3) did not significantly disrupt the
migration profile of treated cells when compared with
control. Similarly, forced expression of the Rnd2-binding
defective mutant Bacurd2(Δ221-316) mutant did not sig-
nificantly disrupt the migration profile of GFP-labelled
cells. Therefore, overexpression of all three mutants didnot disturb migration and this suggests that an intact, full-
length Bacurd2 polypeptide is important for its cell migra-
tion functions within the embryonic cortex.
A Bacurd2:Rnd2 chimeric construct influences radial
migration within the embryonic cortex
Based on our analysis of Bacurd2 and its mutants in
migration (Figure 6), we reasoned that the Bacurd2
polypeptide must coordinate cell migration through its
protein-protein interactions at its N- and C-termini. To
explore the possibility that Bacurd2 might signal cell
migration in concert with Rnd2, we designed a polypep-
tide expression construct comprising a fusion between
Figure 3 The defective migration of Bacurd2 siRNA-treated cells is augmented by co-delivery of human BACURD2. (A) Western blotting
of lysates from P19 embryocarcinoma cells transiently transfected with control siRNA or Bacurd2 siRNAs, together with an expression construct
encoding human BACURD2 as an epitopte-tagged (FLAG) protein. FLAG-BACURD2 protein expression is refractory to Bacurd2 siRNA-mediated
knockdown. (B) In utero electroporation studies with E14 mouse brains electroporated with GFP vector and control siRNA (‘control’), GFP vector
and Bacurd2 siRNA, and Bacurd2 siRNA with the indicated concentrations of BACURD2 expression construct are indicated. (C) Quantitation reveals
that while Bacurd2 siRNA treatment impairs radial migration, co-delivery of 0.4 μg/μl BACURD2 construct restores their migration to control levels,
while co-delivery of 1.0 μg/μl BACURD2 construct only partially restores their migration within the embryonic cortex (N > 1,450 cells counted per
condition; F6,45 = 15; P < 0.0001; two-way ANOVA followed by Bonferroni’s post hoc test). (D) An analysis of their intracortical distribution reveals
that the defective migration of Bacurd2 siRNA-treated cells is restored with co-delivery of 0.4 μg/μl of BACURD2 construct (N > 500 cells per
condition; F6,42 = 15; P < 0.0001; two-way ANOVA followed by Bonferroni’s post hoc test). Graph plots mean ± SEM. Scale bar represents 100 μm.
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the C-terminal sequence of Rnd2(aa181-227) (Figure 7A).
It was recently discovered that the C-terminal (aa181-227)
region of Rnd2 is important for signalling cell migration
in vivo [7], and so we cloned this region of Rnd2 in place
of Bacurd2(aa221-316) to generate a chimeric molecule.
When we introduced this construct into E14.5 born
cortical cells, we found that forced expression of the
Bacurd2:Rnd2 disrupts radial migration in a manner
which was distinct to Rnd2 or Bacurd2 overexpressionalone (Figure 7B). Notably, we found that forced expres-
sion of Bacurd2 led to a significant accumulation of cells
in the IZ and a failure of cells to reach the CP, while
forced expression of Rnd2 resulted in a significant accu-
mulation of cells in the VZ but not the IZ. In contrast,
forced expression of Bacurd2:Rnd2 led to a significant
accumulation of cells in the VZ and IZ. Consistent with
these distinct effects on cell migration, we found that each
different treatment altered the morphology of IZ and CP
cells in different ways (Additional file 6: Figure S6).
Figure 4 The effect of forced expression or knockdown of Bacurd2 on the morphology of GFP-labelled neurons within the IZ and CP
of the E17.5 embryonic cortex. (A) The morphology of neurons within the CP and the IZ in representative brain sections electroporated with
control (GFP only) vector, Bacurd2 expression vector or Bacurd2 siRNAs. Arrowheads point to round-shaped cells. (B) Within the CP, overexpression
or knockdown of Bacurd2 leads to a significant increase in the proportion of round cells, and a decrease in uni/bipolar-shaped cells (N > 300 cells
counted from three brains per condition; F4,45 = 9.63; P < 0.0001, two-way ANOVA followed by Bonferroni’s post hoc test; *P < 0.05, ***P < 0.001).
(C) Within the IZ, overexpression of Bacurd2 leads to a significant increase in the proportion of round cells and a decrease in multipolar-shaped
cells (N > 500 cells counted from three brains per condition; F4,33 = 48.56; P < 0.0001; two-way ANOVA followed by Bonferroni’s post hoc test;
*P < 0.05, ***P < 0.001), but the proportion of uni/bipolar-shaped cells remains unchanged. On the other hand, treatment with Bacurd2 siRNAs
leads to a significant decrease in the proportion of uni/bipolar-shaped cells and multipolar-shaped cells, with no significant difference in the
proportion of round-shaped cells. Scale bar represents 20 μm.
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nificantly disrupted cell migration within the embryonic
E17.5 cortex, including their multipolar-to-bipolar tran-
sition from the IZ to the CP [6,7,10]. Hence, we wanted
to determine if the migration defect of Rnd2-deficient
cells could be restored by modulating Bacurd2 signal-
ling. We began with control experiments to confirm that
the defective migration of Rnd2 shRNA-treated cells
could be corrected by co-delivering an expression con-
struct encoding Rnd2 which is not targeted by the shRNA
vector (Figure 8A,B) [6,7]. Next, we asked whether forced
expression of full-length Bacurd2 could compensate for
the defective migration of Rnd2 shRNA-treated cells, but
we did not observe a restoration of cell migration in our
assay (n = 6 brains per condition, data not shown). In con-
trast, co-delivery of Bacurd2:Rnd2 significantly improved
the migration of Rnd2 shRNA-treated cells (Figure 8A),
with cells reaching the cortical plate at levels not signifi-
cantly different to control treatment (Figure 8B; 39.37% ±
2.57% of cells within the CP of control samples versus33.45% ± 2.4% of Rnd2 shRNA+ Bacurd2:Rnd2 treated
cortices; F8,39 = 17.36; P < 0.0001; two-way ANOVA; post
hoc t-test P > 0.05). In addition to this result, we were also
interested to determine whether I71A/L72A/I73A substi-
tution mutations to the BTB domain of Bacurd2 which
disrupt its binding to Cul3 were relevant to its cell migra-
tion functions. Thus, we performed parallel rescue experi-
ments to co-deliver Bacurd2(3A):Rnd2 (which is defective
in Cul3 binding; see Additional file 7: Figure S7) together
with Rnd2 shRNA in embryonic E14.5 cortical cells. Our
results show that while treatment with Bacurd2(3A):Rnd2
improved the migration of Rnd2 shRNA-treated cells, the
proportion of GFP-labelled cells within the CP remained
significantly decreased compared with control condition
(Figure 8A,B; 13.43% ± 2.76% of cells within the CP of
Rnd2shRNA-treated cortices versus 26.38% ± 2.06% in
Rnd2shRNA+ Bacurd2(3A):Rnd2 treated cortices versus
39.37% ± 2.57% of cells within the CP of control sam-
ples; F8,39 = 17.36; P < 0.0001; two-way ANOVA; post
hoc t-test ***P < 0.0001).
Figure 5 Bacurd2 interacts with its binding partners through distinct regions of the polypeptide. (A) Schematic representation of Bacurd2
polypeptide and its mutant variants used in our analysis. (B) Reciprocal co-immunoprecipitation assays show that Rnd2 interacts with an N-terminal
Bacurd2 truncation mutant but is unable to bind the C-terminal truncation mutant Bacurd2(Δ221-316). (C) Cul3 binds Bacurd2(Δ221-316) but not the
N-terminal truncation mutant Bacurd2(Δ1-109). (D) Mutations to I71/L72/I73 in the Bacurd2(3A) polypeptide sequence disrupt its interaction with Cul3.
(E) Diagrammatic summary of the interactions between Bacurd2 and its interaction partners Rnd2 and Cul3.
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phological transitions undertaken by migrating neurons as
they reach the CP, including their multipolar-to-bipolar
transition as they leave the IZ and enter the CP [6,7]. Thus,
we analysed the migration index of GFP-labelled cells in
our current rescue experiments to understand how neuronsenter the IZ (Figure 8C) and the CP (Figure 8D,E). As a
control experiment, we first confirmed that Rnd2-deficient
cells are defective in their migration from the VZ to the IZ
and CP in a cell autonomous fashion, as previously re-
ported [6,7] (Figure 8C,D,E). We then observed that the IZ
migration defect of Rnd2 shRNA-treated cells is restored
Figure 6 The effect of forced expression of Bacurd2 and its mutated variants on cell migration within the embryonic E17.5 cortex.
(A) Coronal sections of E17.5 embryonic cortex following E14.5 in utero electroporation with a bicistronic construct encoding GFP vector only
(control), or together with Bacurd2 or its mutant variants. (B) Forced expression of Bacurd2 disrupts the migration of GFP-labelled cells in the
embryonic cortex, when compared with control treatment. On the other hand, forced expression of the N-terminal mutants Bacurd2(Δ1-109),
Bacurd2(3A) or the C-terminal Bacurd2(Δ221-316) variant did not significantly disrupt the migration of cells (N > 4,000 cells counted from four to
six brains per condition. Distribution of GFP-labelled cells within the VZ/SVZ, IZ and CP of the E17.5 cortex; F8,96 = 5.38; two-way ANOVA followed
by Bonferroni’s post hoc test which compares each column to control; *P < 0.05; ***P < 0.001). Scale bar, 100 μm.
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levels which are not significantly different to control pro-
file (Figure 8C). In contrast, the defective CP-entry of
Rnd2-deficient cells was efficiently restored only when
Bacurd2:Rnd2 was co-delivered, but not with Bacurd2
(3A):Rnd2 (Figure 8D). Furthermore, we found that the
defective intracortical distribution of Rnd2-deficient cells
was only corrected by co-delivery of Bacurd2:Rnd2, but
not with Bacurd2(3A):Rnd2 (Figure 8E).
Finally, we analysed GFP-labelled neurons within the
IZ and CP to determine whether the abnormal morpholo-
gies of Rnd2 shRNA-treated neurons could be corrected
by co-delivery of Bacurd2:Rnd2. We first investigated the
morphologies of neurons within the IZ of Rnd2 shRNA
electroporated brains and found a significant increase in
the proportion of multipolar-shaped neurons comparedwith control treatment, a result which is consistent with
our previous reports describing failed multipolar-to-
bipolar transition of Rnd2-deficient cells [6-8,10,11]
(Figure 8F). Also, we observed that co-delivery of Rnd2
restores the morphologies of Rnd2 shRNA-treated neu-
rons to a distribution which is not significantly different
to control treatment. In contrast, we found that the
morphological profiles of Rnd2 shRNA + Bacurd2:Rnd2
treated cells within the IZ and CP were restored to a
profile resembling control condition, as were Rnd2shRNA
cells co-treated with Bacurd2(3A):Rnd2 (Figure 8G,H).
Taken together, our results collectively demonstrate that
Bacurd2 coordinates cell migration within the embryonic
cortex and influences the morphological transitions of im-
mature neurons as they transit through the IZ, as well as
when their radial distribution within the CP. Despite the
Figure 7 Forced expression of Bacurd2:Rnd2 impairs radial migration in vivo. (A) Illustration of the protein resulting comprising the
N-terminal region of Bacurd2(1-220) together with the C-terminal region of Rnd2 which mediates the migration of embryonic cortical neurons
in vivo [7]. (B) Forced expression of Bacurd2:Rnd2 impairs cell migration within the embryonic E17.5 cortex, as do cells which overexpress either
Bacurd2 or Rnd2 (N > 2,400 cells counted from three to four brains per condition; F6,63 = 55.34; P < 0.0001; two-way ANOVA followed by Bonferroni’s
post hoc test). Scale bar, 100 μm.
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sents an artificial model of a Bacurd2-Rnd2 signal trans-
ducer, our results suggest that Bacurd2 and Rnd2 promote
cell migration within the embryonic cortex.
Discussion
We previously reported that Rnd2 regulates the migra-
tion of newborn embryonic cortical neurons [6,7];
hence, we wanted to clarify the downstream signalling
pathway through which Rnd2 modulates this activity. In
this study, we have identified Bacurd2 as an interactingpartner to Rnd2 which influences radial migration dur-
ing cerebral cortex development. Notably, both Rnd2
and RhoA signalling are crucial to radial migration
[6,7,19], and Bacurd2 suppresses RhoA to influence cell
migration in vitro [18]. Therefore, we were motivated to
characterise the neuronal functions for Bacurd2 within
the embryonic cortex. We find that disruptions to
Bacurd2 impair cell migration and alter the multipolar-
to-bipolar transition of embryonic cortical neurons.








Figure 8 The defective migration of Rnd2-deficient neurons is restored by co-delivery of Bacurd2:Rnd2. (A,B) The defective migration of Rnd2
shRNA is corrected by co-delivery of Rnd2, Bacurd2:Rnd2 and, to a lesser extent, Bacurd2(3A):Rnd2 (N > 2,000 cells per condition; F8,39 = 17.36;
P < 0.0001; two-way ANOVA by Bonferroni’s post hoc test). (C-E) Cell entry index calculated as the proportion of cells within each subcompartment.
Rnd2 shRNA treatment impairs VZ-to-IZ entry, but is corrected by co-delivery of Rnd2, Bacurd2:Rnd2 and Bacurd2(3A):Rnd2 (F4,13 = 4.210, P = 0.021;
one-way ANOVA) (C). Co-delivery of Rnd2 or Bacurd2:Rnd2 restores IZ-to-CP entry of Rnd2 deficient neurons (F4,13 = 16.31, P < 0.0001; one-way ANOVA)
(D), as well as their migration to the upper CP (N > 295 cells per condition; F4,13 = 18.01, P < 0.0001; one-way ANOVA) (E). Bacurd2(3A):Rnd2 does not
significantly improve IZ-to-CP entry (D), nor the intracortical migration of Rnd2-deficient cells (E). (F) The morphology of IZ and CP neurons. (G) Rnd2
shRNA-treated CP neurons show an increase in the proportion of round cells and a concomitant reduction in uni/bipolar shaped cells (N > 250 cells
per condition; F8,57 = 8.64, P < 0.0001; two-way ANOVA followed by Bonferroni’s post hoc test). Co-delivery of Rnd2, Bacurd2:Rnd2 or Bacurd2
(3A):Rnd2 restores the morphological profile of Rnd2shRNA-treated neurons within the CP. (H) Rnd2 shRNA-treated IZ neurons show a
significant increase in the proportion of multipolar cells and a concomitant reduction in uni/bipolar shaped cells (N > 640 cells per condition;
F8,51 = 3.497, P = 0.0027; two-way ANOVA followed by Bonferroni’s post hoc test). Co-delivery of Rnd2, Bacurd2:Rnd2 and Bacurd2(3A):Rnd2
restored the morphologies of Rnd2 shRNA-treated IZ neurons to control profile. Data was collected from three to four independent brains per
condition. Scale bar represents 100 μm (A) and 20 μm (F).
Gladwyn-Ng et al. Neural Development  (2015) 10:9 Page 10 of 13The ability for immature neurons to migrate is a func-
tion which is sensitive to Rnd2 levels, with too much or
too little disrupting this process [6,7,10]. Given the role
for Bacurd2 in targeting RhoA for degradation by the
Cul3 ubiquitin ligase complex, it is possible that Bacurd2
may act as a substrate adaptor for the degradation of Rnd
proteins. As such, Bacurd2 could target Rnd2 for degrad-
ation via the Cul3 ubiquitin ligase complex so as to pro-
mote radial migration. However, the role for Bacurd2 in
radial migration is also likely to be mediated through
RhoA regulation as well. In the future, it will be important
to determine the relative contributions of both of these
postulated signalling mechanisms for Bacurd2 which in-
fluence the development of cerebral cortical neurons.In our functional studies, we found that truncation of
the C-terminal region of Bacurd2 abolishes its binding
to Rnd2 and disrupts its cell migration functions in em-
bryonic cortical cells. Furthermore, a truncation of the
N-terminal region of Bacurd2 or the introduction of mis-
sense mutations I71A/L72A/I73A within its BTB-domain
(both of which disrupts its binding to Cul3) similarly
abolishes its effects on cell migration in vivo. From these
findings, we surmise that the ability for the Bacurd2 poly-
peptide to control cell migration relies on its N- and
C-terminal domains. With the knowledge that Cul3 and
Rnd2 interact with the C- and N- termini of Bacurd2, re-
spectively, together with our evidence that these proteins
are detected throughout the course of brain development,
Gladwyn-Ng et al. Neural Development  (2015) 10:9 Page 11 of 13our future studies will address their combined roles within
the context of neurodifferentiation.
A significant challenge in our study was to address how
Bacurd2 and Rnd2 might signal to promote cell migration.
We took a drastic approach by tethering a Rnd2(aa181-
227) polypeptide sequence to the C-terminal (aa221-316)
region of Bacurd2. We found that Bacurd2:Rnd2 could
restore the defective migration of Rnd2shRNA-treated
neurons within the embryonic cortex. But, how can we ex-
plain the basis for this rescue? One possible explanation
relates to the migration-promoting functions of Rnd2 and
Bacurd2. In the case of Rnd2, it was reported that its
aa181-227 C-terminal region is important for subcellular
localisation and promotion of activity within the peri-
nuclear region of immature neurons to signal migration
[7,20]. On the other hand, studies with a triple I71A/
L72A/I73A point mutation variant of Bacurd2(3A) protein
show an importance for Cul3 binding to signal cell migra-
tion in a wound-healing assay [18] as well as embryonic
cell migration (this study). When we attempted to recon-
cile these findings through our own experimentation, our
results show that Bacurd2:Rnd2 restores the migration of
Rnd2 shRNA-treated neurons. While the roles for both
Bacurd2 and Rnd2 in neuronal development remain to be
better understood, it will be important to determine if
these molecules are important for the terminal differenti-
ation of cortical neurons, including their dendritic arbor-
isation and synaptic connectivity. More broadly, given the
roles for Bacurd and Rnd proteins in the regulation of the
early steps of neurogenesis [7,12,21,22], a better under-
standing of their combined signalling activities will reveal
their specific contributions to the development and func-
tion of cerebral cortical neurons in health and disease.
Conclusions
The molecular regulation of radial migration is complex
and involves multiple signalling factors which promote
directional movement as well as neurite outgrowth as
immature neurons position themselves within the devel-
oping cerebral cortex. We have identified Bacurd2 as a
new player which promotes the migration of immature
cortical projection neurons in a concentration-sensitive
manner. In addition, we have characterised Bacurd2 as a
novel interacting partner to Rnd2, a known regulator of
radial migration within the embryonic cortex. Our discov-
ery supports the notion that Rnd2 interacts with specific
binding partners (such as Bacurd2) to control neuronal
migration during cortical development.
Methods
Animals - Mice were housed, bred and treated within
the animal facilities at Monash University. All animal
procedures are approved by the Animal Ethics Commit-
tee within Monash University (Licenses MARP/08-104and MARP/2012/068) and are compliant with guidelines
provided by the National Health and Medical Research
Council of Australia.
Cloning, plasmids and siRNA - cDNA for murine
Bacurd2 (also known as Tnfaip1) was amplified from Invi-
trogen clone accession number BC003906 using primers,
5′-CATCATCAATTGatgtcaggggacacctgtctg 3′ (forward)
and 5′-CATCATCAATTGtcagtc acgatgagtggactg-3′ (re-
verse) (Invitrogen, Grand Island, USA). Truncation mu-
tants were constructed by the standard PCR cloning
strategy or DNA synthesis of the entire cDNA (Life
Technologies, Carlsbad, USA). Complementary DNA
(cDNA) fragments were cloned into the EcoRI site of
pEGFP-C2 (Clontech, Mountain View, USA) and pCIG2-
Flag. Expression constructs for Rnd2 and Rnd3 were pre-
viously described [2]. The Bacurd2:Rnd2 cDNA encodes
the following polypeptide which is engineered as a fusion








CNLM (the Rnd2 C-terminal polypeptide sequence is rep-
resented in italics, while the amino acids in bold are
targeted for alanine substitution in the Bacurd2(3A):Rnd2
construct). All constructs were sequenced verified and
plasmids produced using PureYield™ Midi-prep kits
(Promega, Madison, USA).
Immuno-precipitation and Western blotting - Six embry-
onic 14.5 mice brains were homogenised (ProScientific
Pro200 homogenizer, ProScientific, Oxford, USA) in ice-
cold lysis buffer (20 mM Tris (pH 7.5), 150 mM NaCl, 1%
IGEL-PAL and 0.1%SDS supplemented with protease in-
hibitor). The resultant lysate was sonicated then centri-
fuged at 10,000 × g for 20 min at 4°C before transferring
to a fresh tube. The cleared lysate was then incubated with
antibodies: mouse IgG (Millipore, Billerica, USA) and
mouse anti Bacurd2 (Abmart, Shanghai, China) overnight
at 4°C with rotation. The solution was then incubated with
protein A sepharose beads for 2 h at 4°C and then washed
three times with the cold protein lysis buffer. Immuno-
precipitated proteins were eluted with loading buffer
containing 50 mM DTT and samples were analysed on a
10% SDS page gel. Following membrane transfer, the
membranes were incubated with anti-Rnd2 antibodies,
followed by secondary goat-anti-rabbit antibody (Li-Cor
IRDye 680 LT). Signals were detected with Odyssey® in-
frared imaging system (Li-Cor 9201-02, Lincoln USA)
for analysis. Native antibodies to Bacurd2 (epitope is
SPSEDEDTFE Abmart) and Rnd2 (sc-33543; Santa Cruz
Biotechnologies, Santa Cruz, USA) were used.
Gladwyn-Ng et al. Neural Development  (2015) 10:9 Page 12 of 13In utero electroporation - In utero electroporation ex-
periments are performed as described [23]. High-quality,
low endotoxin plasmid preparations (Qiagen, Limburg,
The Netherlands) of DNA vectors were injected at 1 μg/μl
for each plasmid, together with Fast Green (0.05%, Sigma,
St. Louis, USA). For RNAi experiments, Dharmacon
siRNA targeting pools for Bacurd2 were injected at 10 μM
concentration together with GFP expression plasmid at 1
μg/μl concentration. Following recovery from in utero
electroporation, the mice were sacrificed by cervical dis-
location, and the embryonic brains were harvested by dis-
section in cold PBS and preserved for tissue processing,
cryosectioning (16 μm) and fluorescence immunostaining.
Images of brain sections were captured on an epifluores-
cence microscope (Olympus, Tokyo, Japan) equipped with
a CCD camera (SPOT, Sterling Heights, USA). Subdivi-
sions of the embryonic cortex (VZ/SVZ, IZ and CP) were
identified based on cell density as visualised with 4′6-dia-
midino-2-phenylindole (DAPI) staining. Cell counting was
performed blind to the condition on representative fields
of sections of electroporated brains using ImageJ software.Additional files
Additional file 1: Figure S1. Identification of Bacurd2 as a binding
partner to Rnd2 in a yeast two-hybrid assay. Representation of results of
a yeast two-hybrid interaction screen using an Rnd2 bait which lacks its
C-terminal (CAAX) motif. (A) Identification of multiple cDNA prey encoding
Bacurd2 polypeptide. Complementation assays confirm association of
Bacurd2 preys with Rnd2 bait. (B) Growth of yeast transfected with
Rnd2 bait and Bacurd2 prey construct on nutritional selection medium
(lacking histidine and adenine). Double-transfected yeast harbouring
Bacurd2 prey and pLaminC bait, or Bacurd2 prey with p53 bait do not
grow on this selection medium.
Additional file 2: Figure S2. Immunodetection of Bacurd2 and Rnd2.
(A) Western blotting of HEK293T cell lysates transfected with FLAG-Bacurd2
construct and immunoblotted with our mouse monoclonal antibody. A
specific signal of approximately 37 kDa is detected, which corresponds
to the FLAG-Bacurd2 signal in an immunoblot with FLAG antibody.
(B) Western blotting of HEK293T cell lysates transfected with FLAG-Rnd2
construct and immunoblotted with a rabbit polyclonal antibody (Santa
Cruz Biotechnologies, Santa Cruz, USA). A specific signal of approximately
25 kDa is detected and which corresponds to the FLAG-Rnd2 signal in an
immunoblot with FLAG antibody. (C) Western blotting using antibodies
to Bacurd2, Rnd2 and Cul3 on mouse brain lysates harvested from the
indicated timepoints during mouse brain development. The signal for
β-actin was used as a loading control. (D-E) Fluorescence immunostaining
of E14.5 embryonic cortex using preimmune serum (D) or Bacurd2 antibody
(E, green signal). Nuclei were counterstained with DAPI. Scale bar, 50 μm.
Additional file 3: Figure S3. Perturbations to Bacurd2 do not disturb
neuronal differentiation. (A) GFP-labelled cells which co-express Tuj1
(arrow) or do not co-express Tuj1 (arrowheads) are identified in a
representative section of E17.5 embryonic cortex. (B) Quantification
studies of the proportion of GFP-labelled cells which co-express the
neuronal marker Tuj1 (N > 1,700 cells counted from at least three brains
per condition; one-way ANOVA followed by Bonferroni’s post hoc t-test)
reveal no significant difference in GFP+/Tuj1+ cells following overexpression
or knockdown of Bacurd2 (F2,13 = 1.6; P = 0.24; P > 0.5). (C) Two-way ANOVA
analysis of GFP+/Tuj1− cells in each cortical subcompartment reveals no
significant difference in their distribution following overexpression or
knockdown of Bacurd2 (F4,39 = 0.44; P = 0.77; P > 0.5). Graph plots
mean ± SEM. Scale bar, 50 μm.Additional file 4: Figure S4. The defective migration of Bacurd2
siRNA-treated cells is augmented by co-delivery of human BACURD2.
(A) To ask if co-treatment with 0.4 μg/μl or 1.0 μg/μl of BACURD2
construct restores their migration of siRNA-treated cells, we performed
two-way ANOVA followed by Bonferroni’s multiple comparisons test. We
found that treatment with either concentrations of BACURD2 improved
the migration of cortical cells (N > 1,450 cells counted per condition,
F6,45 = 15, P < 0.0001). (B) An analysis of their intracortical distribution
(that is within the lower, medial and upper CP) reveals that the defective
migration of Bacurd2 siRNA-treated cells is restored with co-delivery of
0.4 μg/μl of BACURD2 construct, but treatment with 1.0 μg/μl of BACURD2
did not restore their positioning within the upper CP (N > 500 cells per
condition, F6,42 = 15.27, P < 0.0001; two-way ANOVA followed by
Bonferroni’s post hoc test). Graph plots mean ± SEM. Scale bar represents
100 μm.
Additional file 5: Figure S5. Bacurd2 controls cell shape in vivo. (A)
The morphology of neurons within the CP and the IZ in representative
brain sections electroporated with control (GFP only) vector, Bacurd2
siRNAs or Bacurd2 siRNAs with the indicated concentrations of BACURD2
expression vector. Arrowheads point to round-shaped cells. (B) Within
the CP, knockdown of Bacurd2 leads to a significant increase in the
proportion of round cells and a decrease in uni/bipolar-shaped cells
(N > 300 cells counted from three brains per condition; F6,60 = 24.60;
P < 0.0001; two-way ANOVA followed by Bonferroni’s post hoc test;
*P < 0.05, ***P < 0.001). These effects on cell shape are corrected with
co-delivery of 0.4 μg/μl of BACURD2 construct. (C) Within the IZ, treatment
with Bacurd2 siRNAs leads to a significant decrease in the proportion of
uni/bipolar-shaped cells and multipolar-shaped cells, with no significant
difference in the proportion of round-shaped cells when compared with
control. (N > 500 cells counted from three brains per condition; F6,48 =
22.52; P < 0.0001; two-way ANOVA followed by Bonferroni’s post hoc
test; *P < 0.05, ***P < 0.001). Co-delivery of either 0.4 μg/μl of BACURD2
construct or 1.0 μg/μl of BACURD2 construct corrects these Bacurd2
siRNA-induced changes to cell shape within the IZ. Scale bar represents
20 μm.
Additional file 6: Figure S6. Cell shape profiles following treatment
with Bacurd2:Rnd2, Bacurd2 or Rnd2. Analysis of the morphologies of IZ
and CP neurons following forced expression of Bacurd2:Rnd2, Bacurd2 or
Rnd2. There was an interaction between treatment and distribution of
cell shapes in the CP (N > 190 cells from three to four brains per condition;
F6,60 = 8.332, P < 0.0001; two-way ANOVA followed by Bonferroni’s post
hoc test) (A) and cells within the IZ (N > 390 cells from three to four brains
per condition; F6,51 = 7.537, P < 0.0001; two-way ANOVA followed by
Bonferroni’s post hoc test) (B). Graph plots mean ± SEM.
Additional file 7: Figure S7. Point mutations I71A/L72A/I73A alter
binding to Cul3. (A), Diagrammatic representation of Bacurd2 full-length
polypeptide sequence, along with Bacurd2:Rnd2 contruct, and a Bacurd2
(3A):Rnd2. Yellow indicates the sequence of Rnd2 polypeptide fused to
the C-terminal fragment of Bacurd21-220 polypeptide (see the ‘Methods’
section for polypeptide sequence). Bold letters identify substitution
mutations I71A/L72A/I73A within the BTB-domain of the Bacurd2
polypeptide fragment which mediates Cul3 binding. (B) Reciprocal
co-imunoprecipitation experiments were performed to confirm that the
Bacurd2:Rnd2 interacts with Cul3, but not with Bacurd2(3A):Rnd2. Input
lanes confirm the presence of all proteins evaluated in this experiment.
Abbreviations
bHLH: basic helix-loop-helix; CP: cortical plate; E: embryonic day;
EGFP: enhanced green fluorescent protein; IZ: intermediate zone; lCP:
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